|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Affymetrix Inc., of Santa Clara, Calif., and the Whitehead Institute/MIT Center for Genome Research in Cambridge, Mass., entered a research collaboration to use Affymetrix GeneChip technology to conduct cancer clinical studies. The collaboration is designed to standardize experimental procedures and further validate numerous studies demonstrating the power of expression data for cancer classification. The company said standardization will ensure that expression array data generated from various laboratories will be comparable across multiple clinical sites and studies.
AnorMED Inc., of Vancouver, British Columbia, said it was notified by its licensee, Shire ...